You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Amphotericin B, deoxycholate drug combination

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cryptococcal Meningitis, HIV/AIDS Trial in Zhenjiang (Voriconazole 200mg, amphotericin B deoxycholate (0.4-0.5mg/kg/d),

Unknown status
  • Cryptococcal Meningitis
  • HIV/AIDS
  • Voriconazole 200mg
  • +2 more
  • Zhenjiang, Hangzhou, China
    Lijun Xu
Jan 31, 2021

Pulmonary Mucormycosis Trial in Chandigarh (Inhaled amp B deoxycholate+intravenous liposomal amp B, Intravenous liposomal

Completed
  • Pulmonary Mucormycosis
  • Inhaled amp B deoxycholate+intravenous liposomal amp B
  • Intravenous liposomal amphotericin B alone
  • Chandigarh, India
    Post graduate Institute medical education and research
Jan 24, 2022

Cryptococcal Meningitis, HIV Trial in Worldwide (Fluconazole, Amphotericin B)

Completed
Has Results
  • Cryptococcal Meningitis
  • HIV Infections
  • Los Angeles, California
  • +9 more
Nov 2, 2021

Chronic Hepatitis B Trial in Seoul (Standard of care)

Active, not recruiting
  • Chronic Hepatitis B
  • Standard of care
  • Seoul, Korea, Republic of
  • +3 more
Mar 29, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Shanghai (SI-B001, SI-B003)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Shanghai, Shanghai, China
    Shanghai Oriental Hospital
Jan 13, 2023

Breast Cancer Trial in Boston (Talazoparib, Sacituzumab Govitecan)

Recruiting
  • Breast Cancer
  • Boston, Massachusetts
  • +1 more
Jan 6, 2023

Glioblastoma Trial in Birmingham (Autologous genetically modified gamma-delta T cells, Allogeneic genetically modified

Not yet recruiting
  • Glioblastoma
  • Autologous genetically modified gamma-delta T cells
  • Allogeneic genetically modified gamma-delta T cells
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 16, 2022

Drug-Induced Nephropathy Trial in Cairo (N Acetylcysteine)

Recruiting
  • Drug-Induced Nephropathy
  • N Acetylcysteine
  • Cairo, Egypt
    Helwan University
Nov 7, 2023

Metastatic or Locally Advanced Unresectable Solid Tumors Trial in Canada, Spain, United States (M1774, Drug A (DNA Damage

Recruiting
  • Metastatic or Locally Advanced Unresectable Solid Tumors
  • Houston, Texas
  • +4 more
Jul 7, 2022

Chronic Hepatitis B Trial in Changchun (GLS4, RTV, TAF)

Completed
  • Chronic Hepatitis B
  • Changchun, Jilin, China
    The First Hospital of Jilin University
May 20, 2022

Diabetic Peripheral Neuropathy Trial in Jedda (Group- A (100% weight-bearing; n=14), (moderate-intensity (50-70% heart rate

Completed
  • Diabetic Peripheral Neuropathy
  • Group- A (100% weight-bearing; n=14), (moderate-intensity (50-70% heart rate reserve) aerobic exercise training on the antigravity treadmill, 3 times/week for 12-weeks.
  • +4 more
  • Jedda, Saudi Arabia
    Umm Al-Qura University
Sep 29, 2022

Lung Cancer, Nonsmall Cell, Lung Cancer Stage IV, Lung Cancer Metastatic Trial in Canada, United States (SLC-391, Pembrolizumab)

Not yet recruiting
  • Lung Cancer, Nonsmall Cell
  • +2 more
  • Indianapolis, Indiana
  • +8 more
May 5, 2023

Lymphoma, Large B-Cell, Diffuse Trial in Austria, Germany (Glofitamab, Rituximab, Obinutuzumab)

Not yet recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Linz, Austria
  • +17 more
Mar 22, 2023

Pulmonary Tuberculosis Trial (Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS), Pretomanid, Bedaquiline, OPC-167832, and

Not yet recruiting
  • Pulmonary Tuberculosis
  • Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS)
  • +3 more
  • (no location specified)
Jul 25, 2023

Aggressive Non-Hodgkin Lymphoma, ALK-Positive Large B-Cell Lymphoma, B-Cell Lymphoma, Unclassifiable, With Features Intermediate

Recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • +8 more
  • Polatuzumab Vedotin
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 26, 2023

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Birmingham, Alabama
  • +25 more
Dec 9, 2022

DLBCL, Not Otherwise Specified, High Grade B-Cell Lymphoma, Transformed Indolent B-Cell Non-Hodgkin Lymphoma to DLBCL Trial

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • +2 more
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Sep 5, 2023

Clinical Benefits of Different Formulations of Amphotericin B

Active, not recruiting
  • Efficacy
  • Safety
    • Jinan, Shandong, China
      Rui Yang,MD
    Nov 3, 2023

    HIV/AIDS, Tuberculosis, Pulmonary Trial in Durban (Biktarvy®, TLD- fixed-drug combination single tablet)

    Recruiting
    • HIV/AIDS
    • Tuberculosis, Pulmonary
    • Biktarvy®
    • TLD- fixed-drug combination single tablet
    • Durban, KwaZulu-Natal, South Africa
      CAPRISA Springfield Clinical Research Site
    Mar 14, 2022

    Seasonal Allergic Rhinitis Trial in Mississauga (Treatment A (Dymista): Fixed drug combination of azelastine HCl and fluticasone

    Completed
    • Seasonal Allergic Rhinitis
    • Treatment A (Dymista): Fixed drug combination of azelastine hydrochloride and fluticasone propionate nasal spray at Visit 3
    • +3 more
    • Mississauga, Ontario, Canada
      Cliantha Research
    Feb 11, 2022

    Tumors, Carcinoma, Hepatocellular, Liver Tumors Trial in Japan (E7386, Lenvatinib)

    Recruiting
    • Neoplasms
    • +2 more
    • Kashiwa, Chiba, Japan
    • +2 more
    Nov 8, 2021

    Morbid Obesity Trial in Nijmegen, Nieuwegein (Administration of study drug)

    Completed
    • Morbid Obesity
    • Administration of study drug
    • Nijmegen, Gelderland, Netherlands
    • +1 more
    Oct 16, 2020

    Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco (FOR46, Enzalutamide, Pegfilgrastim)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Prostate Cancer
    • FOR46
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Jun 1, 2022

    Recurrent DLBCL, Recurrent Transformed Non-Hodgkin Lymphoma, Refractory DLBCL Trial in United States (drug, other, biological)

    Active, not recruiting
    • Recurrent Diffuse Large B-Cell Lymphoma
    • +5 more
    • Duarte, California
    • +3 more
    Nov 17, 2022

    Leishmaniasis; Brazilian, Leishmaniasis, Mucocutaneous Trial in Brasilia (Miltefosine 50mg, Pentoxifylline 400mg, Liposomal

    Recruiting
    • Leishmaniasis; Brazilian
    • Leishmaniasis, Mucocutaneous
    • Miltefosine 50mg
    • +2 more
    • Brasilia, DF, Brazil
      Hospital Universitario de Brasilia
    Sep 13, 2023